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BACKGROUND: Women with a medical history of pelvic inflammatory disease, 
endometriosis, polycystic ovary syndrome, diabetes, high blood pressure or other 
selected medical conditions, as well as a family history of cancer, are assumed to 
be at increased risk of endometrial cancer. This study was designed to test these 
assumptions, as evidence for them is lacking. METHODS: We carried out a 
population-based case-control study in Connecticut between 2004 and 2008, 
including 668 endometrial cancer cases and 674 controls from eligible residents 
matched with age. Medical histories and family history of cancers were reported 
and conditional logistic regression was used to estimate odds ratio (OR) and 
corresponding 95% confidence intervals (95% CI). RESULTS: After adjusting for 
various covariates, only the association between a history of high blood pressure 
and endometrial cancer risk remained significant (Adjusted OR = 1.71; 95% CI: 
1.25-2.34). A family history of cancer in the uterus was directly associated with 
endometrial cancer risk (Adjusted OR=2.02; 95% CI: 1.06-3.86). 
CONCLUSIONS: A history of high blood pressure and a family history of uterus 
cancer among 1
st
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Endometrial cancer is the most common type of gynecological cancer in the 
United States (US). Endometrial cancer develops in the lining of the uterus, also 
called the endometrium. This project aims to investigate the potential role of 
medical history and family history of cancer in the etiology of endometrial cancer. 
We hypothesize that a medical history of pelvic inflammatory disease, 
endometriosis, polycystic ovary syndrome, diabetes or other selected medical 
conditions increases the risk of endometrial cancer, and a family history of cancer 
is associated with a higher endometrial cancer risk. 
 
Background 
Endometrial cancer occurs most often in women from the ages of 55 to 70 years 
old and is responsible for 6% of cancer cases in women. The National Cancer 
Institute estimates that in 2011, 46,470 American women were diagnosed with 
endometrial cancer and 8,120 died from the disease.
1 
Prolonged exposure to 
excessive unopposed estrogens results in continued stimulation of the 
endometrium, which is considered a key mechanism in endometrial 
carcinogenesis.
2   
Therefore, factors involving an increased exposure to estrogen 
over time may lead to a higher risk of endometrial cancer. 
 
Various studies have shown that hormone replacement therapy (HRT) is 
associated with the occurrence of endometrial cancer.
3,4 
Other conditions that 
















were also found to have a higher risk of developing 
endometrial cancer, while other gynecological conditions such as endometriosis 





Genetic factors likely play a role in the etiology of endometrial cancer.  A family 
history of endometrial cancer was identified as a risk factor for endometrial 
cancer, although a family history of breast or ovarian cancer had no impact.
13 
Young women with mutation in the hereditary non-polyposis colorectal cancer 





To better understand the etiology of endometrial cancer, we conducted this 
research project to systematically evaluate the potential role of medical history 
and family history of cancer in a population-based case-control study in 





a. Study Participants  
Connecticut residents newly diagnosed with primary endometrial cancer between 
October 2004 and September 2008 were recruited to a population-based case-
control study. Over the study period, study staff from the Rapid Case 
Ascertainment (RCA) at the Yale Cancer Center visited 28 Connecticut hospitals 
on 1-4 week cycles to obtain medical records and diagnosis reports. Out of 1,663 
potentially eligible patients diagnosed at ages 35–80 years, physician consent was 
sought for 1,270 patients and obtained from 1,242 (97.8%). Consent for the 
remaining 393 patients was not sought because of attainment of planned sample 
size. Of the doctor- consented patients, 1,216 were attempted to contact for study 
participation and 26 were not contacted due to completion of the study 
enrollment. Among the patients for whom contact was attempted, 317 (26.1%) 
refused to participate, 19 (1.6%) had died, 13 (1.1%) were too ill to participate, 44 
(3.6%) were unable to be located, 68 (5.6%) were unable to be reached through 
available telephone numbers, 62 (5.1%) were found to be ineligible due to 
ineligible residence (n = 8), mental impairment (n = 7), facility resident (n = 10) 
or language barrier (n = 27), and 25 (2.1%) of potential participants had ineligible 
diagnoses based on review of their medical records. A total of 668 patients 
participated in the study, with a response rate of 59.2% (668 of 1,129) after 
excluding 87 ineligible patients.  
 
Controls were matched to cases by age group (35–51, 52–59, 60–64, 65–69, 70–
74 and 75–79 years) and identified through a pre-letter assisted random-digit 
7 
 
dialing (RDD) method. Each selected landline telephone number was first 
searched in reverse directories to find an address for the number, in order to mail a 
study letter prior to telephone contact. Potential control subjects were initially 
contacted by telephone for determination of study eligibility. Our RDD screen 
gathered 8,168 residence numbers, of which 1,995 appeared to have female 
residents whose ages were within the desired range of our study. Of these, 1,447 
(72.5%) agreed to be further contacted for possible participation in the study. 
From the list of potential candidates, we sequentially contacted 1,248 subjects 
before the end of the study enrollment, and found 111 subjects ineligible for the 
study due to ineligible residence, mental impairment, language barrier, diagnosis 
of cancer and ineligible medical conditions, as well as 92 disqualified for the 
study due to illnesses, death, relocation and no response. Of the remaining 
subjects, 674 completed in-person interview and 371 refused to participate. The 




Upon the participation agreement, in-home appointments were scheduled for in-
person interview and collection of biological specimens. Written informed 
consent was obtained at the appointment prior to the start of interview. A 
structured questionnaire was used for interview, collecting information on birth 
weight, place and date of birth, years of education, self-identified race and 
ethnicity, menstrual and reproductive features during each decade from 20s 
8 
 
through 40s, use of oral contraceptives and hormone replacement therapies, 
medical history of major chronic illnesses and gynecological disorders, family 
history of cancer, smoking and drinking habits, current and lifetime physical 
activities, current and lifetime body weight, including weight at age 20s, 30s, 40s, 
50s, 60s and 5 years before the interview. Subject’s height and other physical 
dimensions were also measured at the time of interview.   
 
 
c. Statistical Analysis 
 
 
Our specific variables of interest included medical histories of pelvic 
inflammatory disease, endometriosis, polycystic ovary syndrome (PCOS), ovarian 
cysts, diabetes, both diabetes and PCOS, wrist fracture/broken after 25 years old, 
hip fracture /broken after 25 years old, aspirin regular intake, high blood pressure, 
high cholesterol/triglycerides/blood lipids, insulin resistance/metabolic syndrome, 
coronary artery disease/heart attack, cirrhosis/hepatitis/other liver problems, 
kidney problem/dialysis, growth hormone replacement therapy, ulcerative 
colitis/bowel inflammation, mumps , cone or punch biopsy (conization) of cervix/ 
cryotherapy /freezing therapy of the cervix, and history of breast, uterus, ovary, 
colorectal, prostate or lung cancer among 1
st
 degree blood relatives (parents, 
siblings, and children). Questionnaire data were first cleaned, merged and 
examined using SAS for distributions, outliers and missing values. Univariate 
analyses were then performed using the t-tests for continuous variables and χ² 
tests for categorical variables. Descriptive statistics on each variable among the 
cases and controls were obtained, including means and standard deviations for 
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numerical variables and frequency distributions for categorical or ordinal 
variables.  Bi-variate logistic regression models were employed to assess the 
association between each variable of interest and case/control status by estimating 
odds ratios (OR) and their 95% confidence intervals. Multivariate logistic 
regression analyses were then performed to adjust for various potential 
confounding variables, including age at interview, race (white or other), education 
(<12 years, 12 years to 3 years college, college/university, graduate school), 
smoking status (current, former, never), body mass index (BMI), age at menarche, 
menopausal status (yes/no), age at menopause, parity, estrogen use ( ever/never), 
HRT (ever/never), oral contraceptive use (ever/never). These covariates were 
chosen based on existing literature and our subject knowledge about the possible 
risk factors of endometrial cancer. All tests were two-sided with an alpha value of 





Table 1 shows the demographic and reproductive characteristics of the study 
population.  Cases and controls were similar with regard to age at interview, 
mother’s age at their birth, numbers of siblings, sisters and elder siblings, birth 
weight, height and birth place. Controls were more likely to be white (p = 0.033) 
and better educated (p <0.001)  -  34.2% and 25.6% of control subjects received 
college or higher education, respectively, compared to 28.3% and 18.9% of cases, 
respectively. Cases had a higher BMI (p < 0.001), higher rates of hypertension (p 
< 0.001), diabetes (p < 0.001), and a greater percentage of relatives with 
endometrial cancer (p = 0.024). In addition, cases were less likely to be smoker (p 
= 0.0187),menopausal hormones (p = 0.006), and they had fewer live births (p < 
0.001) and have younger age at first pregnancy (p < 0.001) compared with 
controls. 
 
Univariate analyses suggest that patients with PCOS (OR = 4.73; 95% CI: 1.35-
16.54), diabetes (OR = 1.95; 95% CI: 1.44-2.64), high blood pressure (OR = 2.06; 
95% CI: 1.65-2.56), high cholesterol/triglycerides and blood lipids (OR= 1.37; 
95% CI: 1.10-1.71) have significantly higher risk of endometrial cancer (Table 2). 
However, after adjusting for various covariates, only high blood pressure 
remained a statistically significant risk factor (Adjusted OR = 1.71; 95% CI: 1.25-
2.34) (Table 2). Other medical conditions examined included  pelvic 
inflammatory disease, both diabetes and PCOS, hip fracture/broken hip after 25 
years of age, insulin resistance/metabolic syndrome, and growth hormone 
11 
 
replacement therapy. Since few (< 1%) subjects had reported a history of these 
medical conditions, we decided not to show detailed results for these conditions. 
No significant associations were found for these conditions, except for pelvic 
inflammatory disease (p = 0.001). 
 
After adjusting for various covariates, multivariate analyses of family history of 
cancer diagnosis suggests that a diagnosis of cancer in the uterus among 1
st
 degree 
blood relatives is significantly associated with an increased risk of endometrial 
cancer (Adjusted OR=2.02; 95% CI: 1.06-3.86) (Table 3).  A history of  other 
types of cancers among 1
st










In this population-based case-control study, a medical history of high blood pressure 
and a family history of endometrial cancer in the 1
st
 degree relatives were 
significantly associated with an increased risk of endometrial cancer.  Although there 
was also an indication of elevated risk for women with pelvic inflammatory diseases, 
the number of subjects reporting such a condition was too few to draw any 
conclusion.  The association between PCOS and endometrial cancer was first 
suggested in 1949 by Speert, who reported an increased incidence of cystic ovaries in 
young women with endometrial cancer.
15
 Jackson and Dockerty in 1957 further 
investigated this association by recruiting 43 patients with PCOS. 16 of these women 
were identified by examining surgical specimens removed from a group of ‘several 
thousand patients’ with endometrial cancer. The remaining 27 patients were women 
with symptoms of the PCOS and a confirmatory ovarian biopsy. Endometrial tissue 
was available for examination in only 15 of these cases. Thirteen samples showed 
‘thickening’, 2 were atrophic, but there were no reported cases of endometrial cancer. 
Nevertheless, Jackson and Dockerty concluded that their most important observation 
concerned the link between the PCOS and endometrial cancer.
16
 It has been argued 
that this study was not reliable due to methodological problems.
17
 Many existing 
studies which claimed to provide evidence of an increased risk of endometrial cancer 
in women with PCOS did not calculate the relative risk.
18 
Although the study by 
Ramzy and Nisker
19
 included a relative risk estimate in their study which compared 
the patients in their study with a cohort of normal women, the numbers were small 
and the p value was just reached the level of statistical significance. Another study 
13 
 
found an association between PCOS and endometrial cancer, but the relation was 
limited only to premenopausal women.
17 
Overall, the evidence for an increased risk of 
endometrial cancer in women with PCOS was inconsistent and inconclusive. The 
finding of our study may provide additional evidence to support  a possible 
association between endometrial cancer and PCOS, but the risk attributable to PCOS 
is likely to be small since fewer women with the condition were involved in 
endometrial cancer. 
 
Diabetes mellitus has been frequently linked to endometrial cancer. Parazinni has 
reported an increased risk of endometrial cancer in diabetic women at age ≥40 years 
(OR=3.1; 95% CI: 2.3–4.2), after controlling for age, calendar year at interview, 
education, body mass index (BMI) (as categorized variable, <25, 25–30, >30), parity, 
oral contraceptive and hormonal replacement therapy use, age at menopause, 
hypertension and smoking.
20  
A population-based prospective cohort study concluded 
that diabetes was associated with a 2-fold increased risk, and combination of diabetes 
with obesity and low physical activity was associated with a further increased risk for 
endometrial cancer. 
21
 Another case-control study showed a history of diabetes was 
significantly related to the risk for endometrial cancer after adjusting for weight and 
other reproductive factors, (RR= 2.0; 95% CI: 1.1- 3.6).
22 
However, our results 
indicated that the association between diabetes and the risk of endometrial cancer 
became statistically insignificant after multivariate adjustment, which may be 
attributable to the relatively small number of women who had diabetes in this study. 
The discrepancy in results compared with previous studies could also arise from the 
14 
 
difference in methodology, covariates being adjusted for, study population, as well as 
sample size. 
 
High blood pressure has been reported as a characteristic of endometrial cancer 
patients, but the data are less convincing than other risk factors such as overweight, 
nulliparity and late manopause. 
23
 Wynder et al. found a higher proportion of cases 
than controls with high blood pressure,
 24
 but there was a similar excess of patients 
with low pressures and the mean pressure did not differ between cases and controls. 
Kaplan and Cole stated the relative risk associated with a history of high blood 
pressure, after controlling for age and weight, was 1.5,
25
 but this did not differ 
significantly from unity. A history of high blood pressure was identified as a 
significant risk factor for endometrial cancer in our study, which confirmed the 
association between the two. The putative biologic mechanisms that underlie this 
association are unclear at present. It has been speculated that long-term exposure to 




Our finding regarding family history of uterus cancer is consistent with other studies. 
There is some evidence for familial aggregation of endometrial cancer. 
26,27
 In a 
case-control study conducted in northern Italy between 1983 and 1993, a family 
history of endometrial cancer was found to increase the risk of the disease.
12 
However, the proportion of cases attributable to this factor was small in that study- 
less than 1% of endometrial cancer patients in that population had a family history. 
In a large multicentre case-control study conducted by Lucenteforte and Talamini in 
15 
 
Italy between 1992 and 2006, ORs were 2.1 (95% CI: 0.7-6.4) for those reporting a 
family history of endometrial cancer and 1.8 (95% CI: 1.0-3.2) for a family history 
of any uterine cancer, indicating a family history of endometrial or any uterine in 




There are several limitations in our study. First, it is possible that the interviewer-
administered questionnaires were subject to differential misclassification due to recall 
bias. Second, medical history data were self-reported, so misreporting (especially 
underreporting) was a possibility. Response rates were modest - 54.9% of cases and 
64.5% of controls approached were finally enrolled in the study. Selection bias may 
have occurred if the cases and controls who participated were not representative of 
the underlying population bases.  
 
Strengths of our study include the population-based study design, the rapid case 
ascertainment, and the use of detailed and thorough medical history questionnaires, 
measuring 27 different types of medical conditions prior to the diagnosis of 
endometrial cancer.  Since our study is population-based and included only incident 
cases who are confirmed by medical records, survival bias was not a concern, and the 
potential for reverse causality was also minimized, if it had not been eliminated 
completely.  
 
Endometrial cancer is currently the fourth most common cancer among women. It is 
estimated that there will be 47,130 new cases and 8,010 deaths from endometrial 
16 
 
cancer in the United States in 2012.
29
 As the incidence/prevalence of high blood 
pressure continues to rise in the US and around the world,
 30
 endometrial cancer 
incidence will likely increase. Future studies need to consider how to decrease the 
risk of developing endometrial cancer in women with known risk-prone medical 



































List of Tables 
 











Number Mean(SD) Number Mean(SD) p value
Age at interview 668 60.6 (9.5) 665 61.5(10.8) 0.123
Mother's age at birth 618 28.6 (6.6) 638 28.3 (6.1) 0.444
Number of siblings 667 3.9 (2.3) 663 3.7 (2.1) 0.730
Number of sisters 665 2.4 (1.4) 661 2.3 (1.3) 0.324
Number of elder siblings 665 1.4 (1.8) 660 1.3 (1.6) 0.817
Birth weight (lb) 392 7.1 (1.4) 409 7.0 (1.5) 0.701
Height (cm) 668 162.7 (6.5) 665 162.5 (6.5) 0.553
Weight (kg) 665 86.5 (23.7) 663 71.5 (16.4) <0.001
BMI 665 32.7 (8.5) 663 27.1 (6.1) <0.001
Number of live births 667 1.8 (1.4) 662 2.1(1.3) <0.001
Age at first pregnancy 667 23.5(4.7) 662 24.7 (5.0) <0.001
Birth Place 0.254
US 602 (90.3) 612 (92.0)
Non-US 65 (9.7) 53(8.0)
Ethinic group 0.033
White 607(90.9) 628 (94.6)
Other 61(9.1) 36 (5.4)
Education <0.001
<12 yrs 237 (35.5) 175 (26.4)
12 yrs. to 3 yrs. college 116 (17.4) 92 (13.9)
College/university 189 (28.3) 227 (34.2)
Graduate school 126 (18.9) 170 (25.6)
Smoking Status 0.0187
Never smoker 364 (54.6) 311 ( 47.0)
Former smoker 251 (37.6) 285 (43.1)
Current smoker 52 (7.8) 66  ( 10.0)
Menopausal status 0.031
Premenopausal 91 (13.7) 119 (18.0)
Postmenopausal 575 (86.3) 586 (88.5)
Oral contraceptive use(ever) 374 (56.3) 440 (66.7) <0.001
Menopausal hormone use(ever) 198 (30.2) 239 (37.5) 0.0056
Menarche age 0.047
<12 year 186 (28.1) 153 (23.3)
>=12 year 476 (71.9) 503 (76.7)
Family history (1st degree 
relative with endometrial 
cancer) 46 (6.9) 27 (4.1) 0.024
Diagnosis of hypertension (ever) 378 (56.7) 257 (38.8) <0.001










*Adjusted for age, race, smoking, menarche age, menopause age, menopause status, parity, BMI, estrogen 




Case Control p value OR (95% CI) Adj* OR  (95% CI)
N (%) N (%)
Endometriosis 0.4469 1.19 (0.76-1.87) 1.29 (0.61-2.73)
No 620 (93.37) 621 (94.38)
Yes 44 (6.63) 37 (5.62)
PCOS 0.0074 4.73 (1.35-16.54) 5.28 (0.49-57.27)
No 652 (97.9) 661 (99.55)
Yes 14 (2.1) 3 (0.45)
Ovary Cyst 0.8256 0.97 (0.74-1.28) 0.87 (0.58-1.30)
No 538 (81.15) 530 (80.67)
Yes 125 (18.85) 127 (19.33)
Diabetes <0.0001 1.95 (1.44-2.64) 1.41 (0.93-2.42)
No 532 (79.64) 588 (88.42)
Yes 136 (20.36) 77 (11.58)
Wrist Fracture/Broken after 25 0.6316 0.90 (0.58-1.40) 1.40 (0.80-2.47)
No 625 (93.98) 617 (93.34)
Yes 40 (6.02) 44 (6.66)
Aspirin regular intake 0.1205 0.84 (0.67-1.05) 0.76 (0.57-1.03)
No 423 (63.51) 393 (59.37)
Yes 243 (36.49) 269 (40.63)
High Blood Pressure <0.0001 2.06 (1.65-2.56) 1.71 (1.25-2.34)
No 290 (43.41) 407 (61.2)
Yes 378 (56.59) 258 (38.8)
High Cholestrol/triglycerides/blood lipids 0.0044 1.37 (1.10-1.71) 1.13 (0.84-1.52)
No 350 (52.79) 399 (60.55)
Yes 313 (47.21) 260 (39.45)
Coronary Artery Disease/ Heart Attack 0.1476 1.47 (0.87-2.47) 1.66 (0.87-3.15)
No 627 (94.57) 639 (96.23)
Yes 36 (5.43) 25 (3.77)
Cirrhosis/Hepatitis/Other liver problem 0.1668 0.68 (0.40-1.18) 0.66 (0.29-1.49)
No 643 (96.55) 630 (95.02)
Yes 23 (3.45) 33 (4.98)
Kidney Problem/ Dialysis needed 0.9102 1.03 (0.63-1.68) 0.78 (0.39-1.56)
No 633 (94.9) 632 (95.04)
Yes 34 (5.1) 33 (4.96)
Ulcerative Colitis/Bowel inflammation 0.7182 0.89 (0.46-1.72) 0.86 (0.38-1.93)
No 649 (97.45) 642 (97.13)
Yes 17 (2.55) 19 (2.87)
Mumps 0.2356 0.86 (0.67-1.10) 0.76 (0.53-1.07)
No 193 (32.94) 176 (29.73)
Yes 393 (67.06) 416 (70.27)
Cone/punch Biopsy of cervix/
Cyrotherapy/Freezing therapy of Cervix 0.1703 1.22 (0.92-1.63) 1.05 (0.70-1.58)
No 523 (80.83) 541 (83.75)




Table 3. Family History of Cancer and Risk of Endometrial Cancer 
 
 
*Adjusted for age, race, smoking, menarche age, menopause age, menopause status, parity, BMI, estrogen 

























Case Control P Value OR (95% IC) Adj.*OR (95%CI)
N (%) N (%)
Breast 0.396 1.13 (0.85-1.51) 0.90 (0.61-1.32)
No 552 (82.63) 561 (84.36)
Yes 116 (17.37) 104 (15.64)
Uterus 0.0234 1.75 (1.07-2.85) 2.02 (1.06-3.86)
No 622 (93.11) 638 (95.94)
Yes 46 (6.89) 27 (4.06)
Ovary 0.5944 1.21 (0.59-2.48) 1.01 (0.40-2.60)
No 651 (97.46) 651 (97.89)
Yes 17 (2.54) 14 (2.11)
Colorectal 0.3018 0.83 (0.58-1.19) 0.77 (0.48-1.22)
No 607 (90.87) 593 (89.17)
Yes 61 (9.13) 72 (10.83)
Prostate 0.1673 1.32 (0.89-1.96) 1.65 (0.96-2.82)
No 607 (90.87) 618 (92.93)
Yes 61 (9.13) 47 (7.07)
Lung 0.7792 0.95 (0.69-1.32) 0.85 (0.55-1.30)
No 587 (87.87) 581 (87.37)
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